Products

Nabla Bio is a biotechnology company specializing in the de novo design of antibody therapeutics through the integration of artificial intelligence (AI) and experimental technologies. Founded by experts from George Church's Lab at Harvard, Nabla Bio combines generative AI models with large-scale multiplex experiments to engineer protein-based therapies, particularly targeting applications where traditional discovery methods have been less effective.

Reshape Biotech offers an AI-powered platform that automates the imaging and analysis of petri and microtiter plates, enabling laboratories to capture high-resolution images, extract data instantly, and obtain reliable results.

ZipBio is a biotechnology company founded in 2023, dedicated to revolutionizing therapeutic development through the use of generative AI. Their proprietary COMPACT™ platform compresses complex biological structures into smaller, de novo-designed proteins that retain full functionality. This innovation addresses the size limitations of traditional therapeutics, enhancing delivery and effectiveness for hard-to-treat diseases.

LIMS Digital is a Unified SaaS-based Laboratory Software Suite designed to revolutionize laboratory operations across diverse sectors. Built to meet the complex needs of Medical and Diagnostic Laboratories, Biorepositories, Environmental Labs, and the Cannabis Industry, LIMS Digital delivers scalable, secure, and fully customizable solutions. Whether you're focused on Clinical Diagnostics, managing sample workflows, or ensuring regulatory compliance, LIMS Digital simplifies every stage—from sam

Biolevate is a pioneering company dedicated to integrating ethical artificial intelligence (AI) into the healthcare sector, aiming to create simple, secure, and collaborative solutions that accelerate medical advancements for a more accessible world. By harnessing the power of AI, Biolevate addresses the complex challenges faced by the life sciences industry, offering tailored solutions that enhance efficiency, compliance, and innovation.

PolyModels Hub is a British software startup specializing in SaaS solutions for pharmaceutical process development. Their platform leverages artificial intelligence to assist scientists in modeling, simulating, and gaining insights across all protocols involved in transforming chemical compounds into safe drug products.

Nanite is a pioneering biotechnology company specializing in the development of non-viral gene delivery systems. Their proprietary platform, SAYER™, integrates artificial intelligence with high-throughput experimental and computational methods to design programmable polymer nanoparticles (PNPs). These PNPs are engineered to deliver a wide range of genetic cargoes with tissue specificity, offering a safer and more efficient alternative to traditional viral vectors. By harnessing AI-driven design,

Surge is a pioneering company dedicated to advancing precision medicine by decrypting the human immune system. Founded by experts in immunology and biomedical informatics, Surge integrates cutting-edge technologies to develop innovative solutions that enhance patient care and optimize healthcare outcomes.

Isomorphic Labs is a London-based company founded in 2021, dedicated to revolutionizing drug discovery through the application of artificial intelligence (AI). As a subsidiary of Alphabet Inc., Isomorphic Labs builds upon the groundbreaking AlphaFold system developed by DeepMind, aiming to model complex biological phenomena and design novel molecules to treat and cure various diseases.

Nextmol is a cloud-based computational chemistry platform designed to accelerate the development of new materials and chemicals. By leveraging advanced molecular modeling and simulation techniques, Nextmol enables researchers and scientists to predict the properties and behavior of molecules, facilitating the design of innovative products across various industries.

Chemix is revolutionizing electric vehicle (EV) battery development by integrating artificial intelligence (AI) to expedite the design process. Traditional battery development is often slow, labor-intensive, and costly. By leveraging AI, Chemix accelerates this process, reducing development time by a factor of ten. Their battery designs are compatible with existing lithium-ion manufacturing infrastructure, facilitating a seamless transition from research and development to mass production. Commi

Terray Therapeutics is a biotechnology company revolutionizing small molecule drug discovery by integrating ultra-high throughput experimentation with generative AI. Their proprietary tNova platform combines precise chemical data generation with advanced computational analysis, enabling the rapid identification and optimization of novel therapeutics. This approach accelerates the drug development process, reduces costs, and enhances success rates, addressing complex therapeutic challenges across

LabGenius is a pioneering biopharmaceutical company that leverages machine learning and automation to revolutionize the discovery and optimization of complex protein therapeutics. Their proprietary platform, EVA™, integrates advanced technologies from machine learning, synthetic biology, and robotics to design, build, and test novel antibody-based treatments efficiently. This approach enables the rapid evaluation of vast numbers of multispecific antibodies, leading to the identification of high-

Talus Bio is a biotechnology company specializing in the discovery and development of therapeutics targeting previously undruggable transcription factors—proteins that regulate gene expression and are implicated in various diseases, including cancer, diabetes, and neurological conditions. Founded in 2020 and based in Seattle, Talus Bio integrates advanced proteomics, synthetic chemistry, artificial intelligence, and computational biology to engineer and analyze drugs, proteins, and genomics at a

CellChorus offers dynamic single-cell analysis through its TIMING™ (Time-lapse Imaging Microscopy in Nanowell Grids) platform, which utilizes visual AI to evaluate how thousands of individual cells move, activate, interact, kill, and survive over time. This technology provides a comprehensive understanding of cellular function, state, and phenotype, surpassing traditional methods that often lack the ability to integrate dynamic cellular behavior with molecular insights at the single-cell level.

Bioptimus is pioneering the development of the first universal AI foundation model for biology, aiming to revolutionize scientific research and biotechnological innovation. By integrating advanced artificial intelligence with comprehensive biological data, Bioptimus seeks to uncover complex biological mechanisms, thereby accelerating discoveries in biomedicine and related fields.

Ignota Labs is a pioneering company dedicated to revitalizing promising yet abandoned drug candidates by addressing safety concerns that have halted their development. Leveraging their proprietary AI platform, SAFEPATH, Ignota Labs integrates deep learning with bioinformatics and cheminformatics to uncover and resolve the underlying mechanisms of drug toxicity. This innovative approach enables the company to rescue drugs that have failed in preclinical or early-phase clinical trials due to safet

Biostate AI is a biotechnology company dedicated to advancing human health through innovative generative AI technologies. Founded in 2023, the company specializes in scalable biodata analysis, offering services that enhance the efficiency and affordability of RNA sequencing and data interpretation.

Yoneda Optimize is a desktop application developed by Yoneda Labs, designed to assist chemists in optimizing chemical reactions efficiently. By leveraging advanced statistical and machine learning algorithms, it enables users to identify optimal reaction conditions, such as temperature, concentration, and catalyst selection, thereby enhancing yield and reducing costs. This tool is particularly beneficial when traditional methods are insufficient or when experimental data is limited.

CytoReason is a pioneering technology company specializing in the development of computational disease models that simulate human diseases at the cellular and tissue levels. By integrating vast datasets, including omics data and cell-focused natural language processing, CytoReason's platform provides a comprehensive understanding of disease mechanisms, patient variability, and treatment effects. This innovative approach enables pharmaceutical and biotech companies to identify new therapeutic tar